Sepracor goes head to head against Wyeth in three patent interferences
Clients Sepracor, Inc.
Jones Day represented Sepracor, Inc. in three patent interferences against Wyeth involving O-desmethylvenlafaxine succinate, and pharmaceutical compositions and dosage forms containing such salt.
Jerussi (Sepracor) v. Hadfield (Wyeth), Interference No. 105,671;
Hadfield (Wyeth) v. Jerussi (Sepracor), Interference No. 105,685;
Hadfield (Wyeth) v. Jerussi (Sepracor), Interference No. 105,689